Synthamin 9 infusion 1litre bags

Maa: Yhdistynyt kuningaskunta

Kieli: englanti

Lähde: MHRA (Medicines & Healthcare Products Regulatory Agency)

Aktiivinen ainesosa:

L-Proline; L-Serine; L-Tyrosine; Sodium acetate; Dipotassium hydrogen phosphate; Sodium chloride; Magnesium chloride; L-Leucine; L-Isoleucine; L-Lysine; L-Valine; L-Phenylalanine; L-Histidine; L-Threonine; Tryptophan; L-Alanine; L-Arginine; Glycine; L-Methionine

Saatavilla:

Baxter Healthcare Ltd

ATC-koodi:

B05BA01

INN (Kansainvälinen yleisnimi):

L-Proline; L-Serine; L-Tyrosine; Sodium acetate; Dipotassium hydrogen phosphate; Sodium chloride; Magnesium chloride; L-Leucine; L-Isoleucine; L-Lysine; L-Valine; L-Phenylalanine; L-Histidine; L-Threonine; Tryptophan; L-Alanine; L-Arginine; Glycine; L-Methionine

Annos:

3.74gram/1litre ; 2.75gram/1litre ; 220mg/1litre ; 4.31gram/1litre ; 5.22gram/1litre ; 2.24gram/1litre ; 1.02gram/1litre ; 4.02gram/1litre ; 3.3gram/1litre ; 3.19gram/1litre ; 3.19gram/1litre ; 3.08gram/1litre ; 2.64gram/1litre ; 2.31gram/1litre ; 990mg/1litre ; 11.38gram/1litre ; 6.32gram/1litre ; 5.66gram/1litre ; 2.2gram/1litre

Lääkemuoto:

Infusion

Antoreitti:

Intravenous

luokka:

No Controlled Drug Status

Prescription tyyppi:

Never Valid To Prescribe As A VMP

Tuoteyhteenveto:

BNF: 09030000; GTIN: 55413760019500 05413760019505

Valmisteyhteenveto

OBJECT 1
SYNTHAMIN 9, 5.5% AMINO ACID INTRAVENOUS
INFUSION
Summary of Product Characteristics Updated 08-Jul-2015 | Baxter
Healthcare Ltd
1. Name of the medicinal product
Synthamin 9, 5.5% Amino Acid Intravenous Infusion
2. Qualitative and quantitative composition
L-Leucine
L-Isoleucine
L-Lysine (as hydrochloride salt)
L-Valine
L-Phenylalanine
L-Histidine
L-Threonine
L-Methionine
L-Tryptophan
L-Alanine
L-Arginine
Amino acetic acid (glycine)
L-Proline
L-Serine
L-Tyrosine
Sodium acetate
Dibasic potassium phosphate
Sodium chloride
Magnesium chloride
Ph. Eur
Ph. Eur
Ph. Eur
Ph. Eur
Ph. Eur
Ph. Eur
Ph. Eur
Ph. Eur
Ph. Eur
Ph. Eur
Ph. Eur
Ph. Eur
Ph. Eur
Ph. Eur
Ph. Eur
Ph. Eur.
Ph. Eur.
Ph. Eur.
Ph. Eur.
0.402% w/v
0.330% w/v
0.319% w/v
0.319% w/v
0.308% w/v
0.264% w/v
0.231% w/v
0.220% w/v
0.099% w/v
1.138% w/v
0.632% w/v
0.566% w/v
0.374% w/v
0.275% w/v
0.022% w/v
0.431% w/v
0.522% w/v
0.224% w/v
0.102% w/v
3. Pharmaceutical form
The product is a sterile aqueous solution of amino acids and
electrolytes for intravenous infusion to
human beings.
4. Clinical particulars
4.1 Therapeutic indications
Synthamin 9, 5.5% Amino Acid Intravenous Infusion provides a
biologically available source of nitrogen
L-amino acids) for amino acids synthesis.
When administered with an adequate source of energy such as
concentrated carbohydrate solutions,
minerals and vitamins, the mixture provides (with the exception of
essential fatty acids) sufficient
parenteral nutrition for patients unable to absorb adequate oral
nutrition.
4.2 Posology and method of administration
The solution is for administration by intravenous infusion through a
central venous catheter with the tip
located in the central vena cava.
The total daily dose of the solution depends upon the patient's
metabolic requirement and clinical
response. The determination of nitrogen balance and accurate daily
body weights, corrected for fluid
balance, are probably the best means of assessing individual nitrogen
requirements.
In addition to meeting nitrogen needs, the rate of adm